The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.
Bloomberg
France will stop funding the homeopathic pills and tinctures made by Boiron SA and rivals at the start of 2021, following the advice of a health panel that spent months reviewing the medicines.
Boiron CEO Valerie Poinsot has said that sales of reimbursed treatments could plummet by 50 percent in France, where the company brings in almost half its revenue, and at least 1,000 jobs hang in the balance.
The Lyon-based company, which competes with Switzerland’s Weleda AG and others in the market for homepathic remedies, has seen its stock price lose about 20 percent in the past two months amid apprehension over the government’s decision.
It dropped as much as 3.9percent in Paris trading.